Hydrazine sulfate has been investigated as an
alternative medical treatment for the loss of appetite (anorexia) and rapid
weight loss (cachexia), which are often associated with cancer. Since the early
1970s, it was suggested that hydrazine sulfate, despite inconclusive evidence,
could be used as an anti-cachexia agent due to its inhibition of
gluconeogenesis. Contradictory results have been obtained in numerous clinical
studies. However, despite being marketed as a dietary supplement, hydrazine
sulfate has not been approved as safe and effective for the treatment of any
medical condition in the United States.
Kitap Adı:
Kanser Hastalarının Başvurduğu Geleneksel Ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü Ile Bakış Ve Onkolojik İlaçlarla Etkileşim
Atıf Sayısı :
